Clinical trials referenced in this document:
Documents that mention this clinical trial
Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
Received: 13 June 2019
Accepted: 28 August 2019
First Online: 9 September 2019
Ethics approval and consent to participate
: This study (Clinicaltrials.gov identification number: NCT01822561) was approved by the Institutional Review Board (IRB) of Tufts Medical Center, Boston, MA, USA.
: Not applicable.
: The authors declare that they have no competing interests.